FDA approves hepatitis C drug
admin 8th August 2017 Uncategorised 0Pharmacy Times More: FDA approves hepatitis C drug Source: MDlinx
read morePharmacy Times More: FDA approves hepatitis C drug Source: MDlinx
read morePharmacy Times More: FDA approves chronic graft versus host disease treatment Source: MDlinx
read moreCompany seeks new data for the first CAR-T treatment submitted in the EU More: Kite begins EU trial of CAR–T therapy Source: News
read moreShire has found a buyer for a former Baxter vaccine plant in Europe that it put up for sale more than a year ago as it continues its manufacturing consolidation after completing two big buyouts last year. More: Shire unloads
read moreAcorda Therapeutics has an activist problem on its hands. After a key patent loss and company cutbacks, the hedge fund Scopia Capital Management is pushing Acorda to put itself on the block. More: Activist pushes Acorda to sell, figuring pipeline's
read moreAmgen’s multiple myeloma treatment and AbbVie’s leukaemia drug among new medicines given the nod in Scotland More: SMC recommends three new medicines Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals